ALNA:Allena Pharmaceuticals Inc - Stock Price Quote and Dividend Data
ALNA STOCK PRICE LATEST CLOSE
$0.08
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Allena Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Allena Pharmaceuticals Inc Stock Price Information
52-Week Low/High Stock Price$0.06 - $1.17
Percent Held by Institutions23.37%
Revenue$0
Net Income$-51,738,000
Cash Flow$-4,557,000
EPS-0.08%
Market Cap$9,156,225
PE Ratio to Industry39%
Debt-Equity Ratio131.09%
Debt-Equity to Industry1.11%
Total Return Last 12 Months-93.06%
Total Return Last 3 Years-98.16%
Total Return Last 5 Years0.00%
Latest Trade DateSep. 07, 2022
Allena Pharmaceuticals Inc Annual Stock Dividends
No Data available for Payment History.
Allena Pharmaceuticals Inc Dividend Payment History
| No dividends retrieved for ALNA |
Allena Pharmaceuticals Inc Other Dividend Details
Allena Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing oral enzyme therapeutics to treat patients with metabolic and kidney disorders. Co. is focused on metabolic disorders that result in excess accumulation of certain metabolites that stimulate inflammation, damage the kidney, and potentially lead to chronic kidney disease (CKD), and end-stage renal disease. Co.'s product candidate, ALLN-346, is an orally administered, urate degrading enzyme for patients with hyperuricemia and gout in the setting of improved CKD. Co. has conducted a Phase 1 program, including both a single-ascending dose and multiple-ascending dose study in healthy volunteers.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Sep. 07, 2022ALNA STOCK PRICE DECREASE: Allena Pharmaceuticals Inc on 09-07-2022 decreased stock price > 10% from $0.10 to $0.07
Aug. 06, 2022ALNA STOCK PRICE DECREASE: Allena Pharmaceuticals Inc on 08-06-2022 decreased stock price > 10% from $0.16 to $0.14
Aug. 05, 2022ALNA STOCK PRICE INCREASE: Allena Pharmaceuticals Inc on 08-05-2022 increased stock price > 10% from $0.11 to $0.16
Jul. 23, 2022ALNA STOCK PRICE DECREASE: Allena Pharmaceuticals Inc on 07-23-2022 decreased stock price > 10% from $0.14 to $0.13
Jul. 14, 2022ALNA STOCK PRICE DECREASE: Allena Pharmaceuticals Inc on 07-14-2022 decreased stock price > 10% from $0.20 to $0.17
Jul. 12, 2022ALNA STOCK PRICE DECREASE: Allena Pharmaceuticals Inc on 07-12-2022 decreased stock price > 10% from $0.23 to $0.20
Jul. 08, 2022ALNA STOCK PRICE INCREASE: Allena Pharmaceuticals Inc on 07-08-2022 increased stock price > 10% from $0.18 to $0.21
Jul. 02, 2022ALNA STOCK PRICE INCREASE: Allena Pharmaceuticals Inc on 07-02-2022 increased stock price > 10% from $0.19 to $0.21
Jul. 01, 2022ALNA STOCK PRICE DECREASE: Allena Pharmaceuticals Inc on 07-01-2022 decreased stock price > 10% from $0.25 to $0.19
Jun. 30, 2022ALNA STOCK PRICE INCREASE: Allena Pharmaceuticals Inc on 06-30-2022 increased stock price > 10% from $0.12 to $0.25
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
